Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
3
×
biotech
boston blog main
boston top stories
life sciences
national blog main
national top stories
3
×
amgen
clinical trials
deals
hepatitis b
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
the medicines company
vir biotechnology
abeona therapeutics
accent therapeutics
achilles therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alirocumab
alopecia areata
amarin
aridis pharmaceuticals
aristea therapeutics
autoimmune diseases
axitinib
beijing
bellus health
biotech ipos
bolt biotherapeutics
boulder/denver blog main
boulder/denver top stories
bridgebio
brii bio
What
drug
3
×
new
3
×
brings
medicines
acquire
adds
advantages
agreed
alliance
areas
bar
billion
bio
biosciences
bio’s
brii
cash
cholesterol
company
compound
deal
disease
earlier
expect
fda
gamble
hepatitis
infectious
launched
market
medco
medco’s
million
mission
mover
novartis
patients
payers
physicians
pipeline
Language
unset
Current search:
drug
×
new
×
" national top stories "
×
" alnylam pharmaceuticals "
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
